Targeting Translation Initiation by Synthetic Rocaglates for Treating MYC-driven Lymphomas

MYC-driven lymphomas, especially those with concurrent MYC and BCL2 dysregulation, are currently a challenge in clinical practice due to rapid disease progression, resistance to standard chemotherapy and high risk of refractory disease. MYC plays a central role by coordinating hyperactive protein sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuan, Bi, Chengfeng, Lu, Ting, Zhang, Weiwei, Yue, Ting, Wang, Cheng, Tian, Tian, Zhang, Xiaoyan, Huang, Yuhua, Lunning, Matthew, Hao, Xinbao, Brown, Lauren E., Devine, William G., Vose, Julie, Porco, John A., Fu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895415/
https://www.ncbi.nlm.nih.gov/pubmed/31171817
http://dx.doi.org/10.1038/s41375-019-0503-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895415/
https://www.ncbi.nlm.nih.gov/pubmed/31171817
http://dx.doi.org/10.1038/s41375-019-0503-z

Ejemplares similares